Nephrotoxicity Associated with Cytoreductive Surgery Combined with Cisplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignant Disease …

C Grillo-Marín, C Antón-Rodríguez, L Prieto… - Journal of Clinical …, 2024 - mdpi.com
Background: Cisplatin is employed in hyperthermic intraperitoneal chemotherapy (HIPEC)
after cytoreductive surgery (CRS) for peritoneal surface malignancies (PSMs). The main …

Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy-A systematic review

SL Solanki, B Salunke, G Gangakhedkar… - European Journal of …, 2024 - Elsevier
The use of nephrotoxic chemotherapeutic agents during hyperthermic intraperitoneal
chemotherapy (HIPEC), carries the risk of postoperative acute kidney injury (AKI). The …

HIPEC-induced acute kidney injury: a retrospective clinical study and preclinical model

LF Liesenfeld, B Wagner, HC Hillebrecht… - Annals of Surgical …, 2022 - Springer
Background Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with
cytoreductive surgery (CRS) is the treatment of choice for selected patients with peritoneal …

Sodium thiosulfate reduces acute kidney injury in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with cisplatin: a single …

A Kurreck, F Gronau, ME Alberto Vilchez… - Annals of Surgical …, 2022 - Springer
Background Cytoreductive surgery (CRS) in combination with hyperthermic intraperitoneal
chemotherapy (HIPEC) represents a multimodal treatment concept for patients with …

Impact of enhanced recovery after surgery on postoperative outcomes for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

B White, F Dahdaleh, SA Naffouje, N Kothari… - Annals of Surgical …, 2021 - Springer
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) have been associated with significant morbidity and increased hospital length of …

Development of a predictive model for risk stratification of acute kidney injury in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal …

M Krause, S Mehdipour, J Veerapong… - Scientific Reports, 2024 - nature.com
Acute kidney injury (AKI) following hyperthermic intraperitoneal chemotherapy (HIPEC) is
common. Identifying patients at risk could have implications for surgical and anesthetic …

Extensive peritonectomy is an independent risk factor for cisplatin HIPEC-induced acute kidney injury

LF Liesenfeld, E Quiring, M Al-Saeedi… - Annals of Surgical …, 2023 - Springer
Background Cisplatin (CDDP)-containing hyperthermic intraperitoneal chemotherapy
(HIPEC) is frequently applied in selected patients with peritoneal malignancies derived from …

Review of cancer therapies for the perioperative physician

A Dabo-Trubelja, V Gottumukkala - Perioperative Medicine, 2023 - Springer
Advances in cancer treatments over the past decades combining chemotherapy with novel
technologies in immunotherapies, radiation therapies, and interventional radiology have …

Risk factors for postoperative complications in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: A meta-analysis …

D Chen, Y Ma, J Li, L Wen, G Zhang, C Huang… - International Journal of …, 2024 - Springer
Objective Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal
chemotherapy (HIPEC) is one of the most effective treatments for intraperitoneal …

Intraoperative hyperoxygenation may negatively affect postoperative cognitive functions in coronary artery bypass graft operations: A randomized controlled study

T Onur, Ü Karaca, F Ata, HE Sayan… - Journal of Cardiac …, 2022 - Wiley Online Library
Objective In this study, it was aimed to compare various parameters during surgery and
postoperative cognitive functions in patients undergoing coronary artery bypass graft …